Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use

NCT04694846 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Lung Non-Small Cell Carcinoma
Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: Nicotine Replacement
DRUG: Bupropion Hydrochloride Controlled-release
DRUG: Varenicline
OTHER: Tobacco Cessation Counseling
OTHER: Questionnaire Administration
OTHER: Quality of Life Assessment
OTHER: Best Practice

Sponsor

Thomas Jefferson University